
De-escalating DAPT to ticagrelor monotherapy cuts bleeding risk in acute coronary syndrome
For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with lower bleeding risk, without ...
Feb 19, 2025
0
0